Double your impact Match My Donation
An innovative collaboration model designed to accelerate next-generation precision cancer immunotherapy through network of leading research centers and top scientists
CRI iAtlas to provide immune bioinformatics tool that aims to improve cancer immunotherapy research and drug effectiveness.
The two nonprofits partnered to support four scientists whose research is focused on developing immunotherapies for patients with fibrolamellar hepatocellular carcinoma.
Researchers at 30 organizations to test algorithms that predict tumor markers from DNA in hunt for new personalized cancer treatments.
Help CRI win the $1 million grand prize.
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
We spoke with six CRI-funded scientists who have worked in Allison’s lab about their experiences and the impact he’s made on their lives and careers before the Nobel Prize ceremony on Monday, December 10, 2018.
The 2018 American Society of Hematology meeting will showcase a variety of basic and clinical advances in blood cancers like leukemia, lymphoma, and myeloma.